These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23297866)

  • 1. Transdermal delivery of lercanidipine hydrochloride: effect of chemical enhancers and ultrasound.
    Shetty PK; Suthar NA; Menon J; Deshpande PB; Avadhani K; Kulkarni RV; Mutalik S
    Curr Drug Deliv; 2013 Aug; 10(4):427-34. PubMed ID: 23297866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combined approach of chemical enhancers and sonophoresis for the transdermal delivery of tizanidine hydrochloride.
    Mutalik S; Parekh HS; Davies NM; Udupa N
    Drug Deliv; 2009 Feb; 16(2):82-91. PubMed ID: 19267299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro permeation of carvedilol through porcine skin: effect of vehicles and penetration enhancers.
    Gannu R; Vishnu YV; Kishan V; Rao YM
    PDA J Pharm Sci Technol; 2008; 62(4):256-63. PubMed ID: 19174954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal delivery of ketorolac tromethamine: effects of vehicles and penetration enhancers.
    Cho YA; Gwak HS
    Drug Dev Ind Pharm; 2004 Jul; 30(6):557-64. PubMed ID: 15285328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of sonophoresis and chemical penetration enhancers on percutaneous transport of penbutolol sulfate.
    Ita KB; Popova IE
    Pharm Dev Technol; 2016 Dec; 21(8):990-995. PubMed ID: 26383739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of penetration enhancers on permeation kinetics of nitrendipine in two different skin models.
    Mittal A; Sara UV; Ali A; Aqil M
    Biol Pharm Bull; 2008 Sep; 31(9):1766-72. PubMed ID: 18758074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal delivery of highly lipophilic drugs: in vitro fluxes of antiestrogens, permeation enhancers, and solvents from liquid formulations.
    Funke AP; Schiller R; Motzkus HW; Günther C; Müller RH; Lipp R
    Pharm Res; 2002 May; 19(5):661-8. PubMed ID: 12069170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
    Yang Z; Teng Y; Wang H; Hou H
    Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
    Aboofazeli R; Zia H; Needham TE
    Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal delivery of ondansetron hydrochloride: effects of vehicles and penetration enhancers.
    Gwak HS; Oh IS; Chun IK
    Drug Dev Ind Pharm; 2004 Feb; 30(2):187-94. PubMed ID: 15089053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancer aided in vitro permeation of atenolol and prazosin hydrochloride through mice skin.
    Reddy LH; Ghosh B
    Indian J Exp Biol; 2001 Jan; 39(1):47-51. PubMed ID: 11349525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel transdermal nanoethosomal gel of lercanidipine HCl for treatment of hypertension: optimization using Box-Benkhen design, in vitro and in vivo characterization.
    Salem HF; El-Menshawe SF; Khallaf RA; Rabea YK
    Drug Deliv Transl Res; 2020 Feb; 10(1):227-240. PubMed ID: 31625026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of matrix type transdermal patches of lercanidipine hydrochloride: physicochemical and in-vitro characterization.
    Mamatha T; Venkateswara Rao J; Mukkanti K; Ramesh G
    Daru; 2010; 18(1):9-16. PubMed ID: 22615587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A preformulation strategy for the selection of penetration enhancers for a transungual formulation.
    Palliyil B; Lebo DB; Patel PR
    AAPS PharmSciTech; 2013 Jun; 14(2):682-91. PubMed ID: 23572254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permeation enhancers compatible with transdermal drug delivery systems. Part I: selection and formulation considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(5):48-55. PubMed ID: 10171148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of permeation enhancers on the release of ketoprofen through transdermal drug delivery systems.
    Singh SK; Durrani MJ; Reddy IK; Khan MA
    Pharmazie; 1996 Oct; 51(10):741-4. PubMed ID: 8941942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dimethylformamide and L-menthol permeation enhancers on transdermal delivery of quercetin.
    Olivella MS; Lhez L; Pappano NB; Debattista NB
    Pharm Dev Technol; 2007; 12(5):481-4. PubMed ID: 17963148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal delivery of carvedilol containing glycyrrhizin and chitosan as permeation enhancers: biochemical, biophysical, microscopic and pharmacodynamic evaluation.
    Sapra B; Jain S; Tiwary AK
    Drug Deliv; 2008 Sep; 15(7):443-54. PubMed ID: 18712622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(6):28-33. PubMed ID: 10171149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of transcutol as a clonazepam transdermal permeation enhancer from hydrophilic gel formulations.
    Mura P; Faucci MT; Bramanti G; Corti P
    Eur J Pharm Sci; 2000 Feb; 9(4):365-72. PubMed ID: 10664476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.